Department of Orthopaedic and Traumatology, Aksaray University Education and Research Hospital, Tacin Street, 68120, Aksaray, Turkey.
Department of Physical Medicine and Rehabilition, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.
Knee Surg Sports Traumatol Arthrosc. 2021 Oct;29(10):3443-3449. doi: 10.1007/s00167-020-06275-z. Epub 2020 Sep 17.
Whether ultra-congruent (UC) or posterior cruciate ligament-stabilized (PS) inserts should be used in posterior cruciate ligament (PCL)-sacrificing total knee arthroplasty (TKA) remains debatable. Therefore, the aim of this prospective randomized controlled study was to compare the isokinetic performance and clinical outcomes of these inserts in PCL-sacrificing TKA.
Sixty-six patients diagnosed with primary knee osteoarthritis were randomly assigned to either the UC or the PS group. There were no significant differences between the groups in terms of age, body mass index or sex. The Knee Society score (KSS) and isokinetic performance results for each patient were recorded preoperatively and at 3, 6 and 12 months postoperatively. The physiatrist that performed the isokinetic tests and the patients were blinded to the study groups.
There were no significant differences between the groups in terms of the preoperative KSS or isokinetic performance. Gradual improvement in the KSS was observed in both groups, but no significant differences were detected between the groups during the whole follow-up period. The UC and PS groups exhibited similar peak extension and flexion torque values normalized to body weight at 3, 6 and 12 months postoperatively (p > 0.05).
The use of UC or PS inserts in TKA did not affect the clinical outcomes or isokinetic performance.The clinical relevance of this study is that the potential differences in clinical outcomes and isokinetic performance between UC and PS inserts do not need to be considered when sacrificing the PCL in TKA.
I.
在牺牲后交叉韧带(PCL)的全膝关节置换术(TKA)中,应使用超等高(UC)还是后交叉韧带稳定(PS)植入物仍存在争议。因此,本前瞻性随机对照研究的目的是比较这些植入物在牺牲 PCL 的 TKA 中的等速性能和临床结果。
66 例被诊断为原发性膝骨关节炎的患者被随机分配到 UC 或 PS 组。两组在年龄、体重指数或性别方面无显著差异。每位患者的膝关节协会评分(KSS)和等速性能结果均在术前和术后 3、6 和 12 个月记录。进行等速测试的物理治疗师和患者对研究组均不知情。
两组患者在术前 KSS 或等速性能方面均无显著差异。两组的 KSS 均逐渐改善,但在整个随访期间组间无显著差异。UC 和 PS 组在术后 3、6 和 12 个月时,体重归一化后的峰值伸展和屈曲扭矩值相似(p>0.05)。
在 TKA 中使用 UC 或 PS 植入物不会影响临床结果或等速性能。本研究的临床意义在于,在 TKA 中牺牲 PCL 时,无需考虑 UC 和 PS 植入物之间在临床结果和等速性能方面的潜在差异。
I。